Theralase Technologies Inc.
TLT.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.06% | 2.68% | 8.15% | 3.80% | 10.35% |
| Total Depreciation and Amortization | -8.25% | -7.90% | -6.32% | -6.85% | -9.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.09% | -8.77% | -15.76% | -13.94% | 17.77% |
| Change in Net Operating Assets | -52.53% | 279.32% | 121.81% | -82.67% | 132.62% |
| Cash from Operations | 6.18% | 37.75% | 19.13% | -4.83% | 31.09% |
| Capital Expenditure | -224.75% | -164.19% | 47.46% | 72.69% | 67.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -224.75% | -164.19% | 47.46% | 72.69% | 67.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.24% | -4.30% | 0.09% | -6.01% | -20.32% |
| Issuance of Common Stock | -13.30% | -29.00% | 33.54% | 130.47% | -10.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -150.00% | 100.00% | 100.00% |
| Cash from Financing | -15.74% | -31.50% | 33.63% | 135.98% | -13.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,234.38% | 109.69% | 115.31% | 104.20% | 101.70% |